<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01835002</url>
  </required_header>
  <id_info>
    <org_study_id>TESOLA</org_study_id>
    <nct_id>NCT01835002</nct_id>
  </id_info>
  <brief_title>Transcorneal Electrical Stimulation - Multicenter Safety Study</brief_title>
  <official_title>Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Multicenter Safety Study of the Okustim ® System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Okuvision GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Okuvision GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the long term effects of transcorneal
      electrostimulation (TES) in patients with retinitis pigmentosa (RP). In a prior study
      (NCT00804102) the results of short term stimulation pointed to a positive effect on the
      visual field and other parameters. In this study, the patients will be stimulated with the
      OkuStim device for half a year and safety parameters will be measured.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ophthalmic examinations</measure>
    <time_frame>6 months</time_frame>
    <description>visual acuity slit lamp microscopy for examination of the anterior and posterior segment intraocular pressure measurement visual field examination Optical coherence tomography (OCT) Digital colour fundus photography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Questionnaires</measure>
    <time_frame>6 months</time_frame>
    <description>Questionnaires to collect the patient's perceived benefits of treatment and handling of the device</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Retinitis Pigmentosa</condition>
  <arm_group>
    <arm_group_label>OkuStim</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electrostimulation Standard Treatment with OkuStim</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electrostimulation</intervention_name>
    <arm_group_label>OkuStim</arm_group_label>
    <other_name>OkuStim</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with retinitis pigmentosa (rod-cone dystrophy) after prescription of
             electrical stimulation by an ophthalmologist

          -  adult patients who are capable of giving consent,

          -  Visual acuity ≥ 0.02

          -  because the electrode is to be positioned on the eye at home, the patient or his
             family members should have sufficient fine motor skills (assessment by the study
             physician)

          -  the patient must be capable of giving consent and a medical assessment that he/she is
             able to participate in the whole study according to the protocol

        Exclusion Criteria:

          -  diabetic retinopathy

          -  neovascularisation of any origin

          -  after arterial or venous occlusion

          -  after retinal detachment

          -  silicone oil tamponade

          -  dry or exudative age-related macular degeneration

          -  macular edema

          -  all forms of glaucoma

          -  any form of corneal degeneration that reduces visual acuity

          -  systemic diseases that are difficult to control or manage, that could endanger the
             normal study schedule

          -  patients in a permanently poor general condition, which could hinder the regular
             attendance at control examinations in the clinic

          -  forms of mental illness related to the bipolar affective and schizoid-affective
             disorders, and all forms of dementia

          -  simultaneous participation in another interventional study or history of interventions
             whose effect may still persist
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florian Gekeler, Prof Dr med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eberhard-Karls-Universität Tübingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Glostrup Hospital and Kennedy Center</name>
      <address>
        <city>Glostrup</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Eye Clinic Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53127</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Augenzentrum München</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Eye Clinic Regensburg</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zentrum für seltene Netzhauterkrankungen, AugenZentrum Siegburg</name>
      <address>
        <city>Siegburg</city>
        <zip>53721</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre for Ophthalmology at the eye clinic Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Germany</country>
    <country>Norway</country>
  </location_countries>
  <removed_countries>
    <country>United Kingdom</country>
  </removed_countries>
  <reference>
    <citation>Naycheva L, Schatz A, Röck T, Willmann G, Messias A, Bartz-Schmidt KU, Zrenner E, Gekeler F. Phosphene thresholds elicited by transcorneal electrical stimulation in healthy subjects and patients with retinal diseases. Invest Ophthalmol Vis Sci. 2012 Nov 1;53(12):7440-8. doi: 10.1167/iovs.12-9612.</citation>
    <PMID>23049087</PMID>
  </reference>
  <reference>
    <citation>Gekeler F; Arbeitsgruppe Elektrostimulation des Department für Augenheilkunde am Universitäts-Klinikum Tübingen. [Transcorneal electrostimulation]. Ophthalmologe. 2012 Feb;109(2):129-35. doi: 10.1007/s00347-011-2450-6. German.</citation>
    <PMID>22350549</PMID>
  </reference>
  <reference>
    <citation>Schatz A, Röck T, Naycheva L, Willmann G, Wilhelm B, Peters T, Bartz-Schmidt KU, Zrenner E, Messias A, Gekeler F. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled exploratory study. Invest Ophthalmol Vis Sci. 2011 Jun 23;52(7):4485-96. doi: 10.1167/iovs.10-6932.</citation>
    <PMID>21467183</PMID>
  </reference>
  <reference>
    <citation>Schatz A, Arango-Gonzalez B, Fischer D, Enderle H, Bolz S, Röck T, Naycheva L, Grimm C, Messias A, Zrenner E, Bartz-Schmidt KU, Willmann G, Gekeler F. Transcorneal electrical stimulation shows neuroprotective effects in retinas of light-exposed rats. Invest Ophthalmol Vis Sci. 2012 Aug 15;53(9):5552-61. doi: 10.1167/iovs.12-10037.</citation>
    <PMID>22807300</PMID>
  </reference>
  <reference>
    <citation>Röck T, Schatz A, Naycheva L, Gosheva M, Pach J, Wilhelm B, Peters T, Bartz-Schmidt KU, Zrenner E, Willmann G, Gekeler F. [Effects of transcorneal electrical stimulation in patients with Stargardt's disease]. Ophthalmologe. 2013 Jan;110(1):68-73. doi: 10.1007/s00347-012-2749-y. German.</citation>
    <PMID>23329121</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2013</study_first_submitted>
  <study_first_submitted_qc>April 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2013</study_first_posted>
  <last_update_submitted>September 7, 2015</last_update_submitted>
  <last_update_submitted_qc>September 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transcorneal electrostimulation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinitis</mesh_term>
    <mesh_term>Retinitis Pigmentosa</mesh_term>
    <mesh_term>Cone-Rod Dystrophies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

